Annual Accounts Payable
$276.40 M
+$38.50 M+16.18%
31 December 2023
Summary:
DexCom annual accounts payable is currently $276.40 million, with the most recent change of +$38.50 million (+16.18%) on 31 December 2023. During the last 3 years, it has risen by +$113.10 million (+69.26%). DXCM annual accounts payable is now at all-time high.DXCM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$326.60 M
+$19.60 M+6.38%
30 September 2024
Summary:
DexCom quarterly accounts payable is currently $326.60 million, with the most recent change of +$19.60 million (+6.38%) on 30 September 2024. Over the past year, it has increased by +$84.20 million (+34.74%). DXCM quarterly accounts payable is now at all-time high.DXCM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.2% | +34.7% |
| 3 y3 years | +69.3% | +55.5% |
| 5 y5 years | +266.1% | +222.1% |
DXCM Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +69.3% | at high | +117.6% |
| 5 y | 5 years | at high | +266.1% | at high | +222.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
DexCom Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $326.60 M(+6.4%) |
| June 2024 | - | $307.00 M(+13.8%) |
| Mar 2024 | - | $269.70 M(-2.4%) |
| Dec 2023 | $276.40 M(+16.2%) | $276.40 M(+14.0%) |
| Sept 2023 | - | $242.40 M(-9.9%) |
| June 2023 | - | $269.10 M(+1.1%) |
| Mar 2023 | - | $266.20 M(+11.9%) |
| Dec 2022 | $237.90 M(+25.6%) | $237.90 M(+20.1%) |
| Sept 2022 | - | $198.10 M(-9.8%) |
| June 2022 | - | $219.60 M(+46.3%) |
| Mar 2022 | - | $150.10 M(-20.7%) |
| Dec 2021 | $189.40 M(+16.0%) | $189.40 M(-9.8%) |
| Sept 2021 | - | $210.00 M(+26.6%) |
| June 2021 | - | $165.90 M(+9.0%) |
| Mar 2021 | - | $152.20 M(-6.8%) |
| Dec 2020 | $163.30 M(+59.6%) | $163.30 M(+10.6%) |
| Sept 2020 | - | $147.60 M(+36.2%) |
| June 2020 | - | $108.40 M(-1.6%) |
| Mar 2020 | - | $110.20 M(+7.7%) |
| Dec 2019 | $102.30 M(+35.5%) | $102.30 M(+0.9%) |
| Sept 2019 | - | $101.40 M(+4.4%) |
| June 2019 | - | $97.10 M(+7.5%) |
| Mar 2019 | - | $90.30 M(+19.6%) |
| Dec 2018 | $75.50 M(+61.7%) | $75.50 M(+30.8%) |
| Sept 2018 | - | $57.70 M(-3.7%) |
| June 2018 | - | $59.90 M(+54.0%) |
| Mar 2018 | - | $38.90 M(-16.7%) |
| Dec 2017 | $46.70 M(+13.6%) | $46.70 M(+100.4%) |
| Sept 2017 | - | $23.30 M(+38.7%) |
| June 2017 | - | $16.80 M(-6.1%) |
| Mar 2017 | - | $17.90 M(-56.4%) |
| Dec 2016 | $41.10 M(+116.3%) | $41.10 M(+56.3%) |
| Sept 2016 | - | $26.30 M(+17.4%) |
| June 2016 | - | $22.40 M(+4.2%) |
| Mar 2016 | - | $21.50 M(+13.2%) |
| Dec 2015 | $19.00 M(+91.9%) | $19.00 M(+13.8%) |
| Sept 2015 | - | $16.70 M(+42.7%) |
| June 2015 | - | $11.70 M(+7.3%) |
| Mar 2015 | - | $10.90 M(+10.1%) |
| Dec 2014 | $9.90 M | $9.90 M(+25.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $7.90 M(+12.9%) |
| June 2014 | - | $7.00 M(+45.8%) |
| Mar 2014 | - | $4.80 M(+14.3%) |
| Dec 2013 | $4.20 M(+7.7%) | $4.20 M(+10.5%) |
| Sept 2013 | - | $3.80 M(+35.7%) |
| June 2013 | - | $2.80 M(+27.3%) |
| Mar 2013 | - | $2.20 M(-43.6%) |
| Dec 2012 | $3.90 M(+39.3%) | $3.90 M(+2.7%) |
| Sept 2012 | - | $3.80 M(+87.8%) |
| June 2012 | - | $2.02 M(+3.5%) |
| Mar 2012 | - | $1.95 M(-30.3%) |
| Dec 2011 | $2.80 M(+59.3%) | $2.80 M(+5.6%) |
| Sept 2011 | - | $2.65 M(+27.3%) |
| June 2011 | - | $2.08 M(+4.1%) |
| Mar 2011 | - | $2.00 M(+13.8%) |
| Dec 2010 | $1.76 M(-32.4%) | $1.76 M(-57.5%) |
| Sept 2010 | - | $4.14 M(+87.1%) |
| June 2010 | - | $2.21 M(+1.8%) |
| Mar 2010 | - | $2.17 M(-16.4%) |
| Dec 2009 | $2.60 M(+131.5%) | $2.60 M(+28.5%) |
| Sept 2009 | - | $2.02 M(+111.7%) |
| June 2009 | - | $956.00 K(-30.1%) |
| Mar 2009 | - | $1.37 M(+21.8%) |
| Dec 2008 | $1.12 M(-26.7%) | $1.12 M(-57.8%) |
| Sept 2008 | - | $2.66 M(+114.9%) |
| June 2008 | - | $1.24 M(-61.8%) |
| Mar 2008 | - | $3.25 M(+111.8%) |
| Dec 2007 | $1.53 M(+83.5%) | $1.53 M(-26.6%) |
| Sept 2007 | - | $2.09 M(-47.4%) |
| June 2007 | - | $3.97 M(+31.4%) |
| Mar 2007 | - | $3.02 M(+261.4%) |
| Dec 2006 | $835.00 K(-86.1%) | $835.00 K(-72.8%) |
| Sept 2006 | - | $3.06 M(+38.3%) |
| June 2006 | - | $2.22 M(-54.0%) |
| Mar 2006 | - | $4.82 M(-19.8%) |
| Dec 2005 | $6.01 M(+489.7%) | $6.01 M(+205.1%) |
| Sept 2005 | - | $1.97 M(-7.8%) |
| June 2005 | - | $2.14 M(+77.6%) |
| Mar 2005 | - | $1.20 M |
| Dec 2004 | $1.02 M(+47.2%) | - |
| Dec 2003 | $692.00 K | - |
FAQ
- What is DexCom annual accounts payable?
- What is the all time high annual accounts payable for DexCom?
- What is DexCom annual accounts payable year-on-year change?
- What is DexCom quarterly accounts payable?
- What is the all time high quarterly accounts payable for DexCom?
- What is DexCom quarterly accounts payable year-on-year change?
What is DexCom annual accounts payable?
The current annual accounts payable of DXCM is $276.40 M
What is the all time high annual accounts payable for DexCom?
DexCom all-time high annual accounts payable is $276.40 M
What is DexCom annual accounts payable year-on-year change?
Over the past year, DXCM annual accounts payable has changed by +$38.50 M (+16.18%)
What is DexCom quarterly accounts payable?
The current quarterly accounts payable of DXCM is $326.60 M
What is the all time high quarterly accounts payable for DexCom?
DexCom all-time high quarterly accounts payable is $326.60 M
What is DexCom quarterly accounts payable year-on-year change?
Over the past year, DXCM quarterly accounts payable has changed by +$84.20 M (+34.74%)